HarvardLaw74 Backup file made by TweetBackup 2012-08-02 15:24:182012-08-02 14:03:54 HarvardLaw74: RT @KeithDarce: Private financing of digital health tripled in 1st half of 2012 to $499B http://t.co/cGPJP6wI via HealthTechZone #startups [Non Social media driven Healthcare startups have the immediate opportunity to achieve solid revenues in an expanding domestic and international market] http://twitter.com/HarvardLaw74/statuses/2308613732094730262012-08-02 00:22:42 HarvardLaw74: 482 recently… [read post]

Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]